
Bridgepoint acquires LGV's LGC for £257m
Bridgepoint has acquired forensics and scientific testing company LGC from LGV Capital for £257m.
Bridgepoint arranged its own financing package for the deal with the existing syndicate of lenders, including HSBC, Lloyds, Bank of Ireland and Societe Generale.
London-based LGC works with police and other authorities to offer toxicology, drug and paternity testing to help investigators at crime scenes. In addition to forensics, the business has three other divisions offering services including genetic and mass spectrometry testing, as well as reference materials for reference testing. The company employs 1,500 people in 28 laboratories in Europe, India, China and the US, and forecasts revenues of £130m for the year ending March 2010.
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote
Permira to take Ergomed private for GBP 703m
Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO
Partners Group to release IMs for Civica sale in mid-September
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Change of mind: Sponsors take to de-listing their own assets
EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater